1. Wong ND, Malik S, Kashyap ML. Dyslipidemia. In: Wong ND, Black HR, Gardin JM, Preventive Cardiology, McGraw-Hill 2005, New York, NY.
2. Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein levels: the Framingham study. JAMA 1986; 256: 2835-8.
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
4. Cholesterol Treatment Trialists' (CTT) Collaborators (writing committee: Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes J). Efficacy and safety of cholesterol-lowering treatment: meta-analysis of individual data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-78
5. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in U.S. adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008; 156: 112-119.
6. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-239.
7. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA; AHA/ACC; National Heart, Lung and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006 May 16; 113(19): 2363-72.
8. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurements of low-density lipoprotein cholesterol: executive summary. National Cholesterol Education Program Working Group on Lipoprotein Measurements. Clin Chem 1995; 41:1414-20.
9. Scharnagl H, Nauck M, Wieland H, Marz W. The Friedwald formula underestimates lDL cholesterol at low concentrations. Clin Chem Lab Med 2001; 39: 426-31.
10. Nauck M, Warnick GR, Rifai N. Methods of measurement of LDL-cholesterol: a critical assessment of direct measurement by homogenous assays versus calculation. Clin Chem 2002; 48: 236-254.
11. Fless GM, Rolih CA, Scanu AM. Heterogeneity of human plasma lipoprotein(a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem 1984; 259:11470-8.
12. Pisani T, Gebski C, Leary E, et al. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay. Arch Pathol Lab Med 1995; 119: 1127-35.
13. PTS Panels® LDL Cholesterol Test Strips [package insert]. Indianapolis, IN: PTS, Inc.; 2005.
14. Cordova CM, Schneider CR, Juttel ID, Cordova MM. Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients. Arq Bras Cardiol 2004; 83: 482-7.
15. PTS Panels® LDL Cholesterol Test Strips [package insert]. Indianapolis, IN: PTS, Inc.; 2005.
|